ReviewFrontiers in oncology2019
Determining Optimal Routes to Surgery for Borderline Resectable Venous Pancreatic Cancer-Where Is the Least Harm and Most Benefit?
Rupaly Pandé et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
ReviewFrontiers in oncology2019
Rupaly Pandé et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.